BP
Ballentine Partners Portfolio holdings
AUM
$6.64B
1-Year Return
16.37%
This Quarter Return
+0.95%
1 Year Return
+16.37%
3 Year Return
+60.04%
5 Year Return
+90.6%
10 Year Return
+147.86%
AUM
$1.13B
AUM Growth
+$110M
(+11%)
Cap. Flow
+$100M
Cap. Flow
% of AUM
8.84%
Top 10 Holdings %
Top 10 Hldgs %
69.32%
Holding
235
New
68
Increased
97
Reduced
48
Closed
4
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$44.9M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
$16.8M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$14.7M |
| 4 |
FedEx
FDX
|
$13.1M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
$12.4M |
Top Sells
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$14.1M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$8.61M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
$3.64M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
$3.57M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$2.75M |
Sector Composition
| 1 | Industrials | 2.13% |
| 2 | Technology | 1.93% |
| 3 | Healthcare | 1.48% |
| 4 | Financials | 1.41% |
| 5 | Consumer Staples | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Accenture
ACN
$156B
| $522K | 0.05% |
4,524
-354
| -7% | -$40.8K |
|
102
Salesforce
CRM
$229B
| $522K | 0.05% |
7,069
+3,824
| +118% | +$282K |
|
103
Invesco QQQ Trust
QQQ
$365B
| $520K | 0.05% |
4,763
| – | – |
|
104
Target
TGT
$42.1B
| $518K | 0.05% |
6,307
+1,403
| +29% | +$115K |
|
105
Stryker
SYK
$150B
| $506K | 0.04% |
4,731
-334
| -7% | -$35.7K |
|
|
CELG
106
DELISTED
Celgene Corp
CELG
| $504K | 0.04% |
5,027
+2,318
| +86% | +$232K |
|
107
RTX Corp
RTX
$212B
| $496K | 0.04% |
7,843
+948
| +14% | +$60K |
|
108
Banco Santander
SAN
$141B
| $491K | 0.04% |
117,532
-25,569
| -18% | -$107K |
|
109
Amgen
AMGN
$151B
| $482K | 0.04% |
3,214
+55
| +2% | +$8.25K |
|
110
Toronto Dominion Bank
TD
$127B
| $481K | 0.04% |
11,171
+1,050
| +10% | +$45.2K |
|
111
Bank of New York Mellon
BK
$74.5B
| $475K | 0.04% |
12,885
-1,447
| -10% | -$53.3K |
|
112
Vanguard S&P 500 ETF
VOO
$726B
| $473K | 0.04% |
2,509
| – | – |
|
113
Biogen
BIIB
$20.3B
| $472K | 0.04% |
1,811
+507
| +39% | +$132K |
|
|
ESRX
114
DELISTED
Express Scripts Holding Company
ESRX
| $469K | 0.04% |
6,830
+655
| +11% | +$45K |
|
115
Vanguard Growth ETF
VUG
$186B
| $462K | 0.04% |
4,340
-268
| -6% | -$28.5K |
|
|
Y
116
DELISTED
Alleghany Corporation
Y
| $458K | 0.04% |
925
+287
| +45% | +$142K |
|
117
Analog Devices
ADI
$119B
| $456K | 0.04% |
7,696
+349
| +5% | +$20.7K |
|
118
US Bancorp
USB
$75.9B
| $455K | 0.04% |
11,218
+892
| +9% | +$36.2K |
|
119
GSK
GSK
$79.4B
| $437K | 0.04% |
8,622
+1,305
| +18% | +$66.1K |
|
120
TSMC
TSM
$1.21T
| $422K | 0.04% |
+16,115
| New | +$422K |
|
121
Novo Nordisk
NVO
$249B
| $421K | 0.04% |
+15,534
| New | +$421K |
|
122
Costco
COST
$424B
| $419K | 0.04% |
2,669
+213
| +9% | +$33.4K |
|
123
iShares Russell Mid-Cap Value ETF
IWS
$14B
| $417K | 0.04% |
5,875
+862
| +17% | +$61.2K |
|
124
Danaher
DHR
$140B
| $414K | 0.04% |
6,500
+2,368
| +57% | +$151K |
|
125
Union Pacific
UNP
$132B
| $411K | 0.04% |
5,165
+500
| +11% | +$39.8K |
|